Market Cap 100.05M
Revenue (ttm) 0.00
Net Income (ttm) -19.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 134,900
Avg Vol 95,670
Day's Range N/A - N/A
Shares Out 41.00M
Stochastic %K 36%
Beta 1.62
Analysts Hold
Price Target $3.25

Company Profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is he...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 967 2633
Address:
1185 Avenue of the Americas, Third Floor, New York, United States
ChrisValdez
ChrisValdez Oct. 2 at 12:26 AM
$ORMP Breakout is just getting started here… Weekly & Monthly Candles below.
0 · Reply
ChrisValdez
ChrisValdez Oct. 2 at 12:23 AM
$ORMP Looking at long term trends here.
0 · Reply
highnihilism
highnihilism Oct. 1 at 10:30 AM
$STN Stantec Trade Count: 2 | Total $: 1.6 K | 0.21 × 90-Day Avg $: 7.4 K | Call $: 1.6 K | Put $: 0 | % Single-Leg: 0% | % Multi-Leg: 0% | % Contingent: 100% $FARM Farmer Bros Trade Count: 8 | Total $: 1.6 K | 0.33 × 90-Day Avg $: 4.6 K | Call $: 1.6 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $DAN Dana Trade Count: 71 | Total $: 2.6 K | 0.02 × 90-Day Avg $: 127.5 K | Call $: 1.6 K | Put $: 1.1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $ORMP Oramed Pharmaceuticals Trade Count: 17 | Total $: 1.6 K | 3.60 × 90-Day Avg $: 437 | Call $: 1.5 K | Put $: 26 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
kshonstocks
kshonstocks Sep. 29 at 7:38 PM
$ORMP b/o
0 · Reply
TOMLONGONE
TOMLONGONE Sep. 11 at 8:26 PM
$ORMP Who is buying this?
1 · Reply
Avi1970
Avi1970 Sep. 3 at 3:54 PM
$ORMP DRTS is rising and ORMP is making a profit on the purchase of DRTS shares, approximately $10 million, and will soon start to rise.
0 · Reply
Avi1970
Avi1970 Sep. 2 at 12:55 PM
$ORMP https://finance.yahoo.com/news/alpha-tau-successfully-treats-first-123000643.html
0 · Reply
Avi1970
Avi1970 Sep. 2 at 12:54 PM
$ORMP https://finance.yahoo.com/news/alpha-tau-successfully-treats-first-123000643.html
0 · Reply
Avi1970
Avi1970 Aug. 27 at 5:42 PM
$ORMP Waiting for a $20 million buyback..
0 · Reply
Avi1970
Avi1970 Aug. 27 at 3:45 PM
$ORMP https://finance.yahoo.com/news/alpha-tau-participate-five-september-123000641.html
0 · Reply
Latest News on ORMP
Oramed Pharmaceuticals Issues Letter to Shareholders

Mar 4, 2025, 9:00 AM EST - 7 months ago

Oramed Pharmaceuticals Issues Letter to Shareholders


Oramed Letter to Shareholders

Jun 26, 2024, 9:05 AM EDT - 1 year ago

Oramed Letter to Shareholders


Oramed Pharmaceuticals Issues Shareholder Update

Feb 9, 2023, 7:55 AM EST - 2 years ago

Oramed Pharmaceuticals Issues Shareholder Update


Oramed's oral insulin pill fails; stock is down 72%

Jan 12, 2023, 8:02 AM EST - 2 years ago

Oramed's oral insulin pill fails; stock is down 72%


Oramed: NASH Biotech Play With Added Bonus

Dec 7, 2022, 3:49 AM EST - 3 years ago

Oramed: NASH Biotech Play With Added Bonus


Oramed Reports Third Quarter 2022 Financial Results

Nov 10, 2022, 4:30 PM EST - 3 years ago

Oramed Reports Third Quarter 2022 Financial Results


Oramed: Oral Insulin For Type 2 Diabetes May Become A Reality

Sep 21, 2022, 5:52 AM EDT - 3 years ago

Oramed: Oral Insulin For Type 2 Diabetes May Become A Reality


Oramed And Oral Insulin: Can This Small Company Really Do It?

Apr 14, 2022, 4:02 PM EDT - 3 years ago

Oramed And Oral Insulin: Can This Small Company Really Do It?


Oramed Appoints Yadin Rozov to its Board of Directors

Apr 4, 2022, 8:25 AM EDT - 3 years ago

Oramed Appoints Yadin Rozov to its Board of Directors


Oramed to Present at Barclays Global Healthcare Conference

Mar 10, 2022, 8:25 AM EST - 3 years ago

Oramed to Present at Barclays Global Healthcare Conference


Oramed Issues Annual Message to Shareholders

Jan 12, 2022, 8:45 AM EST - 4 years ago

Oramed Issues Annual Message to Shareholders


Oramed Pharmaceuticals Appoints Chief Legal Officer

Dec 8, 2021, 7:30 AM EST - 4 years ago

Oramed Pharmaceuticals Appoints Chief Legal Officer


Oramed to Join MSCI USA Small Cap Index

Nov 24, 2021, 8:40 AM EST - 4 years ago

Oramed to Join MSCI USA Small Cap Index


Oramed Reaches 75% Enrollment in Phase 3 Oral Insulin Study

Nov 23, 2021, 8:25 AM EST - 4 years ago

Oramed Reaches 75% Enrollment in Phase 3 Oral Insulin Study


ChrisValdez
ChrisValdez Oct. 2 at 12:26 AM
$ORMP Breakout is just getting started here… Weekly & Monthly Candles below.
0 · Reply
ChrisValdez
ChrisValdez Oct. 2 at 12:23 AM
$ORMP Looking at long term trends here.
0 · Reply
highnihilism
highnihilism Oct. 1 at 10:30 AM
$STN Stantec Trade Count: 2 | Total $: 1.6 K | 0.21 × 90-Day Avg $: 7.4 K | Call $: 1.6 K | Put $: 0 | % Single-Leg: 0% | % Multi-Leg: 0% | % Contingent: 100% $FARM Farmer Bros Trade Count: 8 | Total $: 1.6 K | 0.33 × 90-Day Avg $: 4.6 K | Call $: 1.6 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $DAN Dana Trade Count: 71 | Total $: 2.6 K | 0.02 × 90-Day Avg $: 127.5 K | Call $: 1.6 K | Put $: 1.1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $ORMP Oramed Pharmaceuticals Trade Count: 17 | Total $: 1.6 K | 3.60 × 90-Day Avg $: 437 | Call $: 1.5 K | Put $: 26 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
kshonstocks
kshonstocks Sep. 29 at 7:38 PM
$ORMP b/o
0 · Reply
TOMLONGONE
TOMLONGONE Sep. 11 at 8:26 PM
$ORMP Who is buying this?
1 · Reply
Avi1970
Avi1970 Sep. 3 at 3:54 PM
$ORMP DRTS is rising and ORMP is making a profit on the purchase of DRTS shares, approximately $10 million, and will soon start to rise.
0 · Reply
Avi1970
Avi1970 Sep. 2 at 12:55 PM
$ORMP https://finance.yahoo.com/news/alpha-tau-successfully-treats-first-123000643.html
0 · Reply
Avi1970
Avi1970 Sep. 2 at 12:54 PM
$ORMP https://finance.yahoo.com/news/alpha-tau-successfully-treats-first-123000643.html
0 · Reply
Avi1970
Avi1970 Aug. 27 at 5:42 PM
$ORMP Waiting for a $20 million buyback..
0 · Reply
Avi1970
Avi1970 Aug. 27 at 3:45 PM
$ORMP https://finance.yahoo.com/news/alpha-tau-participate-five-september-123000641.html
0 · Reply
WallStWireAds
WallStWireAds Aug. 4 at 12:34 AM
$ORMP The Next $1B Radiotherapy Bet? Why Alpha Tau Medical May Be One Breakthrough Away https://thefinanceherald.com/the-next-1b-radiotherapy-bet-why-alpha-tau-medical-may-be-one-breakthrough-away/
0 · Reply
ZacksSCR
ZacksSCR Jul. 28 at 9:09 PM
With Substantial Liquidity, $ORMP Has Generated Gains & Income From Investment Portfolio https://buff.ly/21CyOnj
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 25 at 12:28 AM
$ORMP Great piece that accurately captures ORMP's current position. So if you want to refresh your understanding of ORMP or learn about ORMP for the first time, this is essential reading. https://beyondspx.com/article/oramed-pharmaceuticals-oral-delivery-ambitions-face-pivotal-juncture-amidst-strategic-diversification-nasdaq-ormp
0 · Reply
kshonstocks
kshonstocks Jul. 23 at 6:39 PM
$ORMP alert hits some volume coming in
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 23 at 3:49 PM
$ORMP Very bullish. Load up early PT $3.5
0 · Reply
amitzak
amitzak Jul. 18 at 4:50 PM
$ORMP I'm in because: 1. Healthy cash status 2. started also investing in real estate lately 3. the company announced a one-year extension, allowing it to repurchase up to $20 million in value of its common stock, with the program now expiring in June 2026. As of May 2025, Oramed had repurchased approximately $2.5 million worth of shares under this program. 4. the price is near long term support levels.
0 · Reply
positiveguy
positiveguy Jul. 2 at 9:28 PM
$ORMP Trust me do not buy this stock. it is run by incompetent people and liars. the Ceo knows zero about managing a business. He pumped his bullshit drug for 20 years and has nothing to show for it except all the money he pilfered from the company. Look at how much he pays himself and his 90 year old mother and you will throw up. Shocked the SEC has not investigated this scam.
4 · Reply
Newyork_
Newyork_ Jul. 2 at 6:08 PM
$ORMP how are they still going
0 · Reply
CallMeMyBeer
CallMeMyBeer Jun. 27 at 9:15 PM
$ORMP its been years since their phase 3 failure and still no signs of anything working.
0 · Reply
PSDL75
PSDL75 Jun. 20 at 11:17 AM
$ORMP Quick glance at their pipeline, spend and cash - they seem in a decent sport, but not sure what amount of potential they actually have. The oral drug delivery companies appear to not be going anywhere. Though they have a cash runway...but the concerning part is all the financial finagling.. just going to watch this one.
1 · Reply
Itinerant
Itinerant Jun. 5 at 6:23 PM
$ORMP It appears that the company stopped buying their own shares today.
1 · Reply
BigSqueezeComing
BigSqueezeComing Jun. 1 at 7:29 AM
$ORMP Watchlist for monday. PT 3+
0 · Reply